Quarterly shot tested to stop Period-Related migraines
NCT ID NCT06173661
Summary
This study is testing if a quarterly injection called fremanezumab can help prevent migraines that occur around a woman's menstrual period. It involves 72 women aged 18-45 who experience these menstrual migraines. Participants will receive either the real medicine or a placebo injection every three months and track their headaches in a diary to see if the treatment reduces migraine days and improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Health Care Center
Chestnut Hill, Massachusetts, 02467, United States
Conditions
Explore the condition pages connected to this study.